Literature DB >> 12003106

Evidence for electrical remodelling of the atrial myocardium in patients with atrial fibrillation. A study using the monophasic action potential recording technique.

Eva J Hertervig1, Shiwen Yuan, Jonas Carlson, Ole Kongstad-Rasmussen, S Bertil Olsson.   

Abstract

UNLABELLED: Experimental studies have shown that remodelling of the atrial myocardium is linked to the occurrence and perpetuation of atrial fibrillation (AF). Clinical evidence, however, is insufficient. We recorded monophasic action potentials (MAP) during AF from one to three sites in the right atrium in seven patients with chronic AF (CAF) and in 11 patients with paroxysmal AF (PAF). The fibrillatory (FF) interval between two consecutive upstrokes of the MAP was measured using a computer-assisted manual method. The mean, median, 15th, 10th, 5th percentile and shortest FF intervals were calculated in each patient and used as estimates of the local atrial effective refractory period (AERP) during AF. In three patients burst pacing at 400 and 500 beats min(-1) was delivered during the MAP recording. In nine patients, the AERP was also tested using the extra stimulus technique during sinus rhythm.
RESULTS: Thirty-eight recordings were obtained. The shortest FF interval was significantly shorter in patients with CAF as compared with that in patients with PAF (50+/-13 vs. 72+/-31 ms, P<005). Similar differences were seen in the mean, median, 15th, 10th, and 5th percentile FF interval. The AERP during sinusrhythm was significantly longer than the estimated AERPs (P<0 05 to P<0.01) in the nine patients. There was no significant difference in FF interval before and after the burst pacing in the three patients.
CONCLUSION: The AERP was significantly shortened during AF, as compared with that during sinus rhythm, and the AERP shortening was more marked in patients with CAF than in patients with PAF. These clinical findings support the connection between the electrical remodelling and the occurrence and/ or perpetuation of the AF.

Entities:  

Mesh:

Year:  2002        PMID: 12003106     DOI: 10.1046/j.1475-097x.2002.00384.x

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  4 in total

Review 1.  Inflammation and C-reactive protein in atrial fibrillation: cause or effect?

Authors:  Roberto Galea; Maria Teresa Cardillo; Annalisa Caroli; Maria Giulia Marini; Chiara Sonnino; Maria L Narducci; Luigi M Biasucci
Journal:  Tex Heart Inst J       Date:  2014-10-01

2.  Classifying fractionated electrograms in human atrial fibrillation using monophasic action potentials and activation mapping: evidence for localized drivers, rate acceleration, and nonlocal signal etiologies.

Authors:  Sanjiv M Narayan; Matthew Wright; Nicolas Derval; Amir Jadidi; Andrei Forclaz; Isabelle Nault; Shinsuke Miyazaki; Frédéric Sacher; Pierre Bordachar; Jacques Clémenty; Pierre Jaïs; Michel Haïssaguerre; Mélèze Hocini
Journal:  Heart Rhythm       Date:  2010-10-16       Impact factor: 6.343

Review 3.  Potential Biological Markers of Atrial Fibrillation: A Chance to Prevent Cryptogenic Stroke.

Authors:  István Szegedi; László Szapáry; Péter Csécsei; Zoltán Csanádi; László Csiba
Journal:  Biomed Res Int       Date:  2017-07-13       Impact factor: 3.411

Review 4.  Postoperative Atrial Fibrillation Following Cardiac Surgery: From Pathogenesis to Potential Therapies.

Authors:  Yousef Rezaei; Mohammad Mehdi Peighambari; Shayan Naghshbandi; Niloufar Samiei; Alireza Alizadeh Ghavidel; Mohammad Reza Dehghani; Majid Haghjoo; Saeid Hosseini
Journal:  Am J Cardiovasc Drugs       Date:  2020-02       Impact factor: 3.571

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.